News & CommentMore 

Stockdale Securities New Address

Please note that as of 29th January 2018 our new address...Read more »
no collaboration

Citywire Investment Trust Awards 2017

Stockdale Securities are pleased to announce wins for two of our...Read more »
no collaboration

Stockdale Securities reports continued progress

London, 5th October 2017: Stockdale Securities, the London-based institutional stockbroking and...Read more »
no collaboration

Winner – Best Research Award – AIM Awards 2017

Stockdale Securities are proud to announce the win of the Best...Read more »
no collaboration

Stockdale’s Joanna Parsons Tops Thomson Reuters Analyst Awards

We are proud to announce that Stockdale’s Head of Research, Joanna...Read more »
no collaboration

2016 Review

A year ago we renamed our business Stockdale to mark the...Read more »
no collaboration

M&A Advisory 2016 League Table

In 2016, Stockdale acted as financial adviser on 16%* of all...Read more »
no collaboration

Three senior corporate brokers join Stockdale Securities

Stockdale Securities, the London-based institutional stockbroking and corporate advisory firm, announces...Read more »
no collaboration

Clients & TransactionsMore 

Biotech

 

Market Cap £84m

 

Broker

Investment Funds

Main Market IPO & Fundraising

 

£30.6m

 

Sponsor & Broker

Biotech

Placing and Subscription

 

£2.1m

 

Nominated Adviser & Broker

Leisure

Appointment as Nominated Adviser

 

£24m Mkt Cap

 

Nominated Adviser & Joint Broker

Investment Funds

Placing 2026 ZDPs & Offer for Subscription

 

£25m

 

Broker & Financial Adviser

Investment Funds

Tender Offer

 

Mkt cap £33m

 

Broker & Financial Adviser

Technology

Private Placement

 

£3.2m

Mkt Cap £10.2m

 

Broker & Financial Adviser

Speciality Chemicals

Cancellation & Exit Facility

 

£5.1m

 

Nominated Adviser & Broker